Maja Thim Larsen

Albumin-based drug delivery: harnessing nature to cure disease

Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam et al. · Molecular and Cellular Therapies · 2016 · 661 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs

Maja Thim Larsen, Ole Aalund Mandrup, Karen Kræmmer Schelde et al. · Journal of Controlled Release · 2020 · 43 citations

Medicine, Cancer Biology, Oncology +17

Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement

Maja Thim Larsen, Helen Rawsthorne, Karen Kræmmer Schelde et al. · Journal of Controlled Release · 2018 · 36 citations

Life Sciences, Biochemistry, Molecular Biology +11

An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications

Matthias Kuhlmann, Jonas B.R. Hamming, Anders Voldum et al. · Molecular Therapy — Nucleic Acids · 2017 · 29 citations · Full text

Pharmacy, Biomolecular Engineering, Molecular Biology +17

Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter

Anne Brinkø, Maja Thim Larsen, Heidi Koldsø et al. · Bioorganic & Medicinal Chemistry · 2016 · 16 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14